Summary
NEW HAVEN -- Sopherion Therapeutics Inc. has raised $47 million in a second round of funding. Company officials said they plan to move the corporate headquarters to Princeton, N.J., next month, but the research facilities will remain in New Haven.
TL Ventures of Wayne, Penn., led the second round of funding for the 300 George St. biotechnology company. Seven other companies contributed to the venture financing, the second this year. One venture company, Sprout Group in New York, put up $12 million.See the full content of this document
Extract
Sopherion Gains $47 Million in Venture Financing
In January, Sopherion received $26 million in a first-round funding -- a record for the l...
See the full content of this document
Sponsored links
